+ All Categories
Home > Science > Donor HLA Typing 101

Donor HLA Typing 101

Date post: 24-May-2015
Category:
Upload: allcells
View: 932 times
Download: 5 times
Share this document with a friend
Description:
In the development of cancer immunotherapies, vaccines, and autoimmune disease treatments, researchers are increasingly aware of the importance of host human leukocyte antigens (HLA) in understanding the complexity of immune responses. HLA allelic variants have distinct binding affinities for peptide antigens during presentation, and thus regulate auto-antigen and pathogen-specific T cell activation. HLA polymorphisms have been correlated with disease risk, immune responses to infectious disease, as well as adverse responses to therapies. In this webinar, we will review the genetics and biology of HLA types and explain the technology underlying HLA identification. We will also provide some examples of how HLA-typing can be a valuable investment during early stage drug-development in human primary cells.
Popular Tags:
15
Your Reliable Source of Human Primary Cells Donor HLA Typing 101: How HLA Characterization Can Accelerate Your Research
Transcript
Page 1: Donor HLA Typing 101

Your Reliable Source of Human Primary Cells

Donor HLA Typing 101:How HLA Characterization Can Accelerate Your Research

Page 2: Donor HLA Typing 101

HLA – What is it?

HLA typing technology

Applications

Q&A

1

2

3

4

Page 3: Donor HLA Typing 101

Macrophage or APC

B cells

foreign protein

peptide / HLA

T cells

Activated T cells

60-sec Immunology Review

Page 4: Donor HLA Typing 101

ER

Major Histocompatibility

Complex (MHC)

Antigen-specific T cell

T cell Receptor (TCR)

Human Leukocyte Antigen (HLA)

HLA molecules “present” peptide to T cells

Page 5: Donor HLA Typing 101

CD4 T helper cell

HLA Class IIHLA Class I

CD8+ Cytotoxic T cell

Cytosolic proteins

Proteosome

All nucleated cells

Extracellular pathogens

(except cross-presentation)

Lysosome

Only APCs

13-25 aa 9-22 aa

2 flavors of HLA

Page 6: Donor HLA Typing 101

CLA

SS I

1

CLA

SS II

HLA diversity is the result of genetic polymorphisms

HLA-B8

*0801*0802*0803

….. *0821

HLA- B > 3,000 known alleles

Page 7: Donor HLA Typing 101

• Crossmatch

• Microcytotoxicity Test

• Mixed Lymphocyte Reaction Assay

• Immunophenotyping

• SSP Genotyping

• SSO Genotyping

Evolution of HLA Typing

Page 8: Donor HLA Typing 101

SSO Genotyping Method

Page 9: Donor HLA Typing 101

HLA Data Analysis

Page 10: Donor HLA Typing 101

Transplantation

Forensics

Disease-related Biomarkers

HLA-typing applications

Vaccine Development

Page 11: Donor HLA Typing 101

HLA and Autoimmune disease

Disease HLA Allele

Celiac Disease HLA-DQ8, -DQ2

Type I Diabetes HLA-DRB1*04:01

Multiple Sclerosis HLA-DRB1*15:01

RA (ankylosingspondylitis)

B27

Behçet's disease HLA-B51

Page 12: Donor HLA Typing 101

Transplantation

Forensics

Disease-related Biomarkers

HLA-typing applications

Immunogenicity

Vaccine Development

Page 13: Donor HLA Typing 101

HLA and Immunogenicity

• HLA-B*57:01

Ostrov et al, PNAS, 2012

Page 14: Donor HLA Typing 101

AllCells HLA-typed

Primary Cells*AllCells

Immunoassays

PBMC

T cells

B cells monocytes

Cytokine Release Assays

MLR Assays

T cell proliferation

T helper cell polarization

HLA typing at AllCells

* Primary cells from healthy donors or diseased patients

Page 15: Donor HLA Typing 101

Bruce Sun

Sr. Manager, Product and Application Development

Please direct offline questions to [email protected] or

[email protected]

www.allcells.com/technical-support/

www.allcells.com/support/webinars/

Contact Information


Recommended